ALN OATF Vena Cava Filter
- Conditions
- Pulmonary Embolism
- Interventions
- Device: Filter implantation
- Registration Number
- NCT05785676
- Lead Sponsor
- Assistance Publique - H么pitaux de Paris
- Brief Summary
Migration of a thrombus in the pulmonary circulation is the leading cause of pulmonary embolism (PE). It can be prevented mechanically by implanting a vena cava filter (VCF) in the inferior vena cava. The implation of a VCF is indicated for patients with acute PE and a contraindication to anticoagulation, with an acute deep vein thrombosis (DVT) without PE and a contraindication to anticoagulation or with acute venous thromboembolism (less than 3 months) in whom an interventional gesture at hemorrhagic and thromboembolic risk contraindicates anticoagulation.
The purpose of this study is to describe the rates of implantation, removal and complications associated with the use of the optional ALN OATF VCF in current practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Patient implanted with an ALN OATF VCF
- Patient informed
- Minor patient
- Adult patient under a legal protection measure
- Pregnant, parturient or breastfeeding women
- Patient who refused to participate
- Patient who cannot or does not wish to be followed by the Interventional Radiology Department
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Vena Cava Filter Filter implantation Participants implanted with the vena cava filter OATF (ALN)
- Primary Outcome Measures
Name Time Method Filter implantation day 0 Rate of technical success of filter implantation
- Secondary Outcome Measures
Name Time Method Filter removal up to 1 year Rate of filter removal
Trial Locations
- Locations (1)
AP-HP - H么pital Europ茅en Georges-Pompidou Paris, France
馃嚝馃嚪Paris, Ile-de-France, France